DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Jiang R, Tan Z, Deng L. et al.
Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.
Hepatology 2011;
54 (03) 900-909
We do not assume any responsibility for the contents of the web pages of other providers.